Analystreport

ChemoCentryx Inc (NASDAQ: CCXI) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $58.00 price target on the stock.

Churchill Capital Corp XI - Class A Ordinary Shares  (CCXI) 
Last churchill capital corp xi - class a ordinary shares earnings: 3/10 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.chemocentryx.com